Cardiol Therapeutics (CRDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 50,211 | 55,172 | 59,097 | 66,943 | 22,762 |
| Receivables | 346 | 316 | 384 | 325 | 306 |
| TOTAL | $51,916 | $57,651 | $62,169 | $69,529 | $24,579 |
| Non-Current Assets | |||||
| PPE Net | 218 | 242 | 268 | 284 | 311 |
| Intangibles | 242 | 264 | 283 | 303 | 318 |
| TOTAL | $460 | $506 | $551 | $587 | $629 |
| Total Assets | $52,377 | $58,157 | $62,720 | $70,116 | $25,208 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,864 | 5,991 | 4,408 | 3,877 | 2,001 |
| Other current liabilities | 1,489 | 2,872 | 3,576 | 5,315 | N/A |
| TOTAL | $7,391 | $8,900 | $8,021 | $9,228 | $2,043 |
| Non-Current Liabilities | |||||
| TOTAL | $27 | $38 | $48 | $58 | $59 |
| Total Liabilities | $7,418 | $8,938 | $8,068 | $9,286 | $2,102 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | N/A | 61,923 | N/A |
| Common Shares | 112,576 | 112,090 | 112,954 | 114,035 | 71,362 |
| Retained earnings | -81,932 | -77,497 | -73,016 | -66,639 | -61,376 |
| Other shareholders' equity | 2,695 | 4,333 | 3,875 | 3,333 | 3,430 |
| TOTAL | $44,958 | $49,219 | $54,651 | $60,830 | $23,106 |
| Total Liabilities And Equity | $52,376 | $58,157 | $62,720 | $70,116 | $25,208 |